1 Feb 2016 13:08
TyraTech, Inc.
('TyraTech' or 'the Company')
Director's Dealings
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified today that Alan Reade, Non-Executive Chairman, purchased 250,000 ordinary shares in the Company at a price of 2.699 pence per ordinary share.
Following this transaction, Alan is interested in 14,033,620 ordinary shares in the Company representing 3.83 per cent. of TyraTech issued share capital.
*-ends*-
For further information please visit: www.tyratech.com or contact:
TyraTech Inc.Alan Reade, Non-Executive ChairmanBruno Jactel, Chief Executive Officer | Tel: +44 7841978709Tel: +1 919 415 4340 |
|
SPARK Advisory Partners Limited, Nominated AdviserMatt Davis / Mark Brady | Tel: +44203 368 3551 |
|
Allenby Capital Limited , Joint BrokerChris Crawford | Tel: +44 20 3328 5656 |
|
Whitman Howard Limited, Joint BrokerRanald McGregor-Smith/ Niall Devins | Tel: +44 20 7659 1234 |
|
Belvedere Communications (PR) John West / Kim van Beeck: |
Tel: +44 20 3567 0510
|
|